Product Pathways - Metabolism
Fetuin A (F180) Antibody #5258
|5258S||100 µl (10 western blots)||---||In Stock||---|
|5258||carrier free and custom formulation / quantity||email request|
Already purchased this product? Write a Review.
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting, IP=Immunoprecipitation
Specificity / Sensitivity
Fetuin A (F180) Antibody detects endogenous levels of total fetuin A protein.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Phe180 of human fetuin A protein. Antibodies are purified by protein A and peptide affinity chromatography.
Fetuin A is produced by liver and secreted to plasma, and selectively concentrated in bone matrix. It is synthesized as a precursor and processed to generate 2 chains that are held together by a disulfide bond. It is a systemically acting calcification inhibitor (1). Reduced level of fetuin A in serum is associated with increased cardiovascular mortality in dialysis patients (2,3). Fetuin A can inhibit insulin-induced tyrosine phosphorylation of the insulin receptor tyrosine kinase and insulin receptor substrate-1 (4). Fetuin A deficient mice show high insulin sensitivity and high levels of serum fetuin A are associated with insulin resistance in humans (5,6).
- Schafer, C. et al. (2003) J Clin Invest 112, 357-66.
- Westenfeld, R. et al. (2007) Trends Cardiovasc Med 17, 124-8.
- Westenfeld, R. et al. (2009) J Am Soc Nephrol 20, 1264-74.
- Auberger, P. et al. (1989) Cell 58, 631-40.
- Mathews, S.T. et al. (2002) Diabetes 51, 2450-8.
- Stefan, N. et al. (2006) Diabetes Care 29, 853-7.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.